Symptoms
Common signs and symptoms of Kaposi Sarcoma include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Kaposi Sarcoma.
Kaposi sarcoma develops when human herpesvirus 8 (HHV-8) infects cells in a person with a weakened immune system.
Kaposi sarcoma develops when human herpesvirus 8 (HHV-8) infects cells in a person with a weakened immune system. This virus, also called Kaposi sarcoma-associated herpesvirus, remains inactive in healthy individuals but becomes problematic when immune defenses cannot keep it under control. The virus specifically targets cells that line blood vessels and lymphatic vessels, causing them to grow abnormally and form the characteristic lesions.
The immune system weakness that allows HHV-8 to cause cancer can result from several conditions.
The immune system weakness that allows HHV-8 to cause cancer can result from several conditions. HIV infection represents the most common cause worldwide, as the virus progressively destroys immune cells called CD4+ T cells. Organ transplant recipients develop Kaposi sarcoma because they must take medications that suppress their immune system to prevent organ rejection. Some people are born with genetic immune deficiencies that make them vulnerable to this cancer.
Infection with HHV-8 spreads through saliva, sexual contact, and potentially through blood transfusions or organ transplants from infected donors.
Infection with HHV-8 spreads through saliva, sexual contact, and potentially through blood transfusions or organ transplants from infected donors. The virus is more common in certain geographic regions, particularly parts of Africa and the Mediterranean. However, simply carrying the virus does not guarantee cancer development - the immune system must be significantly compromised for Kaposi sarcoma to occur.
Risk Factors
- HIV infection or AIDS
- Taking immunosuppressive medications after organ transplant
- Being infected with human herpesvirus 8 (HHV-8)
- Male gender
- Mediterranean or Eastern European ancestry
- Living in areas where HHV-8 is common
- Having other sexually transmitted infections
- Advanced age in certain populations
- Genetic immune system disorders
Diagnosis
How healthcare professionals diagnose Kaposi Sarcoma:
- 1
Diagnosing Kaposi sarcoma typically begins when a doctor notices characteristic skin lesions during a physical examination.
Diagnosing Kaposi sarcoma typically begins when a doctor notices characteristic skin lesions during a physical examination. The distinctive purple, red, or brown appearance of these lesions often suggests the diagnosis, but confirmation requires a tissue biopsy. During this procedure, a small sample of the suspicious tissue is removed and examined under a microscope by a pathologist who looks for the specific cellular changes caused by HHV-8 infection.
- 2
Doctors also perform blood tests to check for HIV infection and measure immune system function, particularly CD4+ T cell counts.
Doctors also perform blood tests to check for HIV infection and measure immune system function, particularly CD4+ T cell counts. Testing for HHV-8 antibodies can confirm exposure to the virus, though this test is not always necessary for diagnosis. If Kaposi sarcoma is confirmed, additional imaging studies help determine the extent of disease throughout the body.
- 3
Staging workup may include chest X-rays, CT scans of the chest and abdomen, and endoscopy to check for lesions in the digestive tract.
Staging workup may include chest X-rays, CT scans of the chest and abdomen, and endoscopy to check for lesions in the digestive tract. These tests help doctors classify the disease as limited (affecting only skin) or disseminated (involving internal organs). The staging process guides treatment decisions and helps predict outcomes. Blood tests also monitor overall health, including liver and kidney function, before starting treatment.
Complications
- Kaposi sarcoma can cause both physical and psychological complications that significantly impact quality of life.
- Skin lesions may become painful, bleed easily, or develop secondary bacterial infections that require antibiotic treatment.
- Large lesions can interfere with normal activities, while lesions on the feet or legs may make walking difficult.
- The visible nature of skin lesions often causes emotional distress and social isolation.
- When Kaposi sarcoma affects internal organs, more serious complications can develop.
- Lung involvement may cause persistent cough, shortness of breath, or life-threatening breathing difficulties.
- Gastrointestinal lesions can lead to bleeding, bowel obstruction, or severe diarrhea that results in dehydration and malnutrition.
- Lymph node involvement may cause significant swelling in arms, legs, or face that impairs normal function.
- Early recognition and treatment of these complications can prevent more serious outcomes and improve long-term survival.
Prevention
- Preventing Kaposi sarcoma focuses primarily on avoiding infection with HHV-8 and maintaining a healthy immune system.
- Since the virus spreads through saliva and sexual contact, practicing safe sex and avoiding sharing personal items like toothbrushes or razors can reduce transmission risk.
- People at high risk should discuss prevention strategies with their healthcare providers, particularly those who are HIV-positive or planning to receive organ transplants.
- For HIV-positive individuals, taking antiretroviral medications as prescribed represents the most effective prevention strategy.
- Maintaining an undetectable viral load and healthy CD4+ T cell counts dramatically reduces the risk of developing Kaposi sarcoma.
- Regular medical monitoring allows for early detection and treatment of any immune system changes that might increase cancer risk.
- Organ transplant recipients should work closely with their medical teams to find the lowest effective dose of immunosuppressive medications.
- Some newer immunosuppressive drugs may carry lower risks of cancer development.
- Blood and organ screening for HHV-8 in high-risk areas could potentially prevent transmission, though this is not yet standard practice in most locations.
Treatment for Kaposi sarcoma depends on the type and extent of disease, along with the patient's overall immune status.
Treatment for Kaposi sarcoma depends on the type and extent of disease, along with the patient's overall immune status. For people with HIV-related Kaposi sarcoma, the most effective initial treatment involves highly active antiretroviral therapy (HAART) to restore immune function. When the immune system recovers, lesions often shrink or disappear without additional cancer treatment. This approach has revolutionized outcomes for HIV-positive patients with Kaposi sarcoma.
Local treatments work well for limited skin lesions and include radiation therapy, cryotherapy (freezing), laser therapy, and topical medications like imiquimod.
Local treatments work well for limited skin lesions and include radiation therapy, cryotherapy (freezing), laser therapy, and topical medications like imiquimod. Intralesional injections of chemotherapy drugs can shrink individual lesions without causing systemic side effects. These approaches are particularly useful for lesions in cosmetically sensitive areas or those that cause physical discomfort.
Systemic chemotherapy becomes necessary for widespread or aggressive disease, especially when internal organs are involved.
Systemic chemotherapy becomes necessary for widespread or aggressive disease, especially when internal organs are involved. Common regimens include liposomal doxorubicin, paclitaxel, or combination chemotherapy protocols. These medications can effectively shrink lesions and control symptoms, though they may cause side effects like fatigue, nausea, and increased infection risk. Treatment decisions must balance cancer control with maintaining quality of life.
Promising new treatments include antiangiogenic drugs that block blood vessel formation, immunotherapy agents, and antiviral medications specifically targeting HHV-8.
Promising new treatments include antiangiogenic drugs that block blood vessel formation, immunotherapy agents, and antiviral medications specifically targeting HHV-8. Clinical trials continue to investigate combinations of these approaches. For transplant recipients, reducing immunosuppressive medications while maintaining organ function represents a delicate balance that requires close medical supervision.
Living With Kaposi Sarcoma
Living with Kaposi sarcoma requires ongoing medical care and attention to both physical and emotional well-being. Regular follow-up appointments allow doctors to monitor disease progression, adjust treatments, and address new symptoms promptly. People with this condition should maintain open communication with their healthcare team about any changes in existing lesions or the appearance of new ones. Keeping a photo record of skin lesions can help track changes over time.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 9, 2026v1.0.0
- Published by DiseaseDirectory